Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts break down its benefits and risks.

The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...

Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve deeper into the ...

Jenny Mollen, Jason Biggs’ wife, shared how microdosing GLP1 medication led to an ER visit and raised concerns about mental health effects ...

By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

Around a fifth of users report not losing the expected amounts of weight on Mounjaro, and doctors have some answers ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...